An eye toward the clinic, Israel’s Compugen works to transform itself admin June 8, 2017 Blog Read more: https://www.bioworld.com/report/BWT053017Compugen.pdf You Might Also Like Gamida #Cell Announces First Patient #Transplanted in Phase 3 Registration Study of NiCord for #Blood #Cancers March 6, 2017 New technology can predict resistance to chemotherapy May 30, 2017 Pharma Two B raises $30M for Parkinson’s phase 3 from Biogen-backed fund, adds ex-Pfizer CEO to board February 28, 2017
Gamida #Cell Announces First Patient #Transplanted in Phase 3 Registration Study of NiCord for #Blood #Cancers March 6, 2017
Pharma Two B raises $30M for Parkinson’s phase 3 from Biogen-backed fund, adds ex-Pfizer CEO to board February 28, 2017
